15 years+ Industry research experience. Only Company which focuses on small product segmentation reports.
Global healthcare chatbots market was valued USD 160.3 Million in 2020, expanding at 21% CAGR (2022-2030) to reach USD 563 million at the end of 2030. Technology advancements coupled with growing demand for automation in healthcare industry are considered as the prime reasons for the expansion of this market.
A chatbot is a type of interactive application which uses artificial intelligence and a set of rules to interact with humans by means of the textual conversation method. This facilitates assisting the users into various sectors. The healthcare sector has been an eye-catching market industry for companies in the development of chatbot applications for patients and clinicians.
The healthcare chatbots market is growing in terms of market growth rate across the globe due to the most important factor like the increasing internet connectivity and rising adoption of smart devices. Other factors such as the benefits of healthcare chatbots, escalating patient population worldwide, growing requirement for virtual health assistance are also contributing to the market growth. Furthermore, the prologue of chatbots in terms of the social media platforms, the rising requirements for the healthcare chatbots for considering the medical operating expenses of patients, and the surfacing of cloud-based architecture are some factors that may provide beneficial opportunities for chatbot developers in increasing their customer foundation which may drive the market growth in the future.
On the other hand, the shortage of experts for generating chatbots, the lack of awareness and skilled healthcare IT professionals as well as the concerns associated with data privacy may restrain the market growth over the forecast period.
In terms of revenue, the North American region is dominating the global healthcare chatbots market due to the rising disposable income and large investments in the research & development of highly developed healthcare chatbots, growing demand for virtual assistance as well as increasing internet connectivity, and the augmented adoption of mobility solutions in healthcare organizations. Similarly, the European region is dominating the healthcare chatbots market owing to the rising awareness, benefits of healthcare chatbots, expanding the number of collaborations between prominent market players and healthcare providers for the implementation of healthcare chatbots in the region.
Various key players in the global healthcare chatbots market cover Infermedica, PACT Care BV, Sensely Inc., Anboto, Ada Digital Health Ltd., eGain, Babylon Healthcare Services Limited, eCreations, HealthTap Inc., Nuance Communications Inc., Your.MD Limited, Next IT Corp., Baidu Inc., Synthetix Ltd., Buoy Health Inc., Inbenta Technologies Inc., Woebot Labs Inc., Creative Virtual, GYANT.COM INC., and CX Company.
Global Healthcare Chatbots Market: By Component
Global Healthcare Chatbots Market: By Deployment Model
Global Healthcare Chatbots Market: By End-User
Global Healthcare Chatbots Market: By Application
Global Healthcare Chatbots Market: Regional Segmentation Analysis
Global energy-based aesthetic devices market valued USD 3.2 Billion in 2021 and is predicted to progress at a healthy CAGR of 12.07% from 2022 to 2030 to attain a value of USD 9.6 Billion by year 2030.
The energy-based aesthetic products are utilized in the treatment of wrinkles, sun-damaged skin, and unwanted injuries. These products are widely used to develop positive, pleasant, or artful user appearance.
Due to the growing innovations in the sector of aesthetic devices, increasing awareness concerning medical aesthetics, and obesity augmentation all over the world are expected to boost the demand for energy-based aesthetic devices products. In addition, the increase in disposable incomes and high trends of body changing in the emergent countries of India and China are projected to present lucrative opportunities for the energy-based aesthetic device growth in the market during the forecast period. On the other hand, the high expenditure on such treatments may hamper the market growth in the future.
The energy-based aesthetic device mainly focuses to reduce the excess sagging skin or getting rid of stubborn fat to get the skin tightening. For the rectification of aesthetic treatment procedures, there are numerous technical procedures carried out that consist of non-invasive devices, invasive devices, and minimally invasive devices. Presently, totally automated aesthetic devices are obtainable intended for their end-users.
Furthermore, owing to the COVID-19 outbreak, the demand for energy-based aesthetic devices is negatively impacted, and the routine health care services have remained suspended. To slow down the spreading of the virus, all countries across the globe adopted lockdown, which came into effect on March 23, 2020. Ever since then, the clinics offering light-based and intense pulsed light services have remained closed for the treatments.
Regionally, the European market is projected to witness stable growth during the forecast period as a result of growth in the aged population base. In terms of revenue, North America is dominating the worldwide energy-based aesthetic devices industry and is expected to remain dominant in the upcoming years due to the augment in healthcare spending, and technological developments in energy-based aesthetic devices. It has also been the largest market for medical aesthetics, particularly in the U.S. market, and is considered as the platform for improvement in aesthetics procedures.
Moreover, the Asia-Pacific region is likely to observe lucrative growth in the future because of some factors like changing lifestyle patterns, increasing disposable income, powerful presence of regional industry players, awareness among patients, increasing personal expenditures, better-untapped opportunities in the region.
Companies such as Johnson & Johnson, Genesis Biosystems Inc., Lumenis Ltd., Bausch Health Companies, Alma Lasers Inc., Syneron Medical Limited, Cutera, Candela Corporation, Cynosure Inc., Hologic Inc., Merz Pharma GmbH & Co. KGaA, Syneron Medical Ltd., Venus Concept, IRIDEX Corporation, Sciton, TRIA Beauty Inc., among others are covered in the market. Key players are engaged in strategic mergers and acquisitions to expand their market presence. For example, medical aesthetics product manufacturer, Cynosure acquired the MyEllevate Surgical Suture System, escalating the company's range of innovative simply invasive facial rejuvenation treatment.
Global Energy-Based Aesthetic Devices Market: By Product
Global Energy-Based Aesthetic Devices Market: By Application
Global Energy-Based Aesthetic Devices Market: Regional Segmentation Analysis
[215+ Pages Report] According to the research report, the global mental health software market generated USD 2.01 Billion in 2020, and is expected to record USD 5.5 billion by 2030, witnessing a CAGR of 12.03% from 2021 to 2030.
The term mental/behavioral health software (MHS) is a type of healthcare management software allowing the counselors, mental health experts, and psychologists to know the behavioral and mental pattern of the people and signifying them with personalized treatment arrangements a result of dealing against the anxiety, addiction stress, depression, and so forth on their individual level. It is proficient for the retrieval, storage, and distribution of radiological, pharmacological, and laboratory data remarks.
Mental/Behavioural health software lets people who are struggling with their mental health get assistance. It's an online guide that helps them deal with their mental health issues, and it also offers the ability to connect with psychologists or therapists through audio or video chat.
The one thing that mental health software does is to provide emotional support. Its purpose is to provide emotional support for anyone who is struggling with their mental health. It can help them identify what they're feeling and what they need in order to feel better again.
As depression is a commonly found mental ailment where more than 264 million populations of all age group go through depression and the large healthcare expenditure for treating mental health related issues or mental disorders are a major worry for governments. The requirement for and production of extreme paperwork that results in loss of productivity among clinicians and improper profits phase managing by mental health organizations are some key factors emerging in the higher expenditure treatments. This, in turn, has resolved such issues focusing on and the adoption of mental health software while minimizing the medication errors and paperwork adding productivity by assuring fast patient access of data where there is the minimization of the healthcare expenditures, and improvement of workflow effectiveness. This is boosting the global mental health software market across the globe.
For mental health providers, the privacy of data is the main concerns in the mental health, as these providers aren’t allowable to share the data on patients who are suffering from some mental disease with any person who is not concerned in the treatment of that specific patient. Any healthcare expert not related to that particular case can entry the patient’s record with the integration of information using mental IT tools. This can restrain the growth of mental health software market over the forecast period.
On the basis on components, the behavioral/mental health software market is segmented into software and support services. As per research report, the support services segment estimated a largest share of the behavioral/mental health software market in 2021. The recurring requirement of support services (such as software upgrades and maintenance) is the major factor supporting its growth.
On the basis of end users, community clinics segment shows highest CAGR in the behavioral/mental health market during the forecast period
On the basis of end users, the behavioral/mental health software market has been segmented into community clinics, hospitals, and private practices. As per research report, in 2021, the community clinics segment estimated a largest share and growing government initiatives to support these facilities and growing patient preference for community clinics are likely to drive behavioral/mental health software adoption in this segment.
North America to dominate the behavioural/mental health software market
The mental health software market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. As per mental health software market analysis, North America occupied maximum share in the mental health software market due to the major increase in the occurrence of mental disorders in the region. Also, emergent countries like Canada and the U.S. are considered to be the largest market revenue due to the government funding for mental health facilities in the future.
Some major players operating in the global mental health software market are Advance Data Systems, Cerner, Cure MD, Core Solutions, Epic systemscorporations, Allscripts, Mindlinc, Mediware, Kareo, Netsmart, The Echo Group, NextGen Healthcare, Valant, Qualifacts, Accumedic, Credible, Welligent, Meditab, Advancedmd, Compulink.
For example, NextGen Healthcare is engaged in developing innovative EHR software and practice management systems to the healthcare industry. The company offers financial management, population health, and clinical solutions for medical and dental. Recently, in 2019, the company announced an agreement to acquire OTTO Health to expand its telemedicine capabilities.
This report segments the global mental health software market as follows:
Global Mental Health Software Market: By Component
Global Mental Health Software Market: By Delivery Model
Global Mental Health Software Market: By Functionality
Global Mental Health Software Market: By End-User
Global Mental Health Software Market: Regional Segmentation Analysis
[197+ Pages Report] According to recent research report, the global EEG Wearable Device Market generated US $1.9 Billion in 2020, and is expected to record US $2.5 Billion by 2030, witnessing a CAGR of 8% from 2021 to 2030.
Electroencephalography (EEG) is the device that is used in measuring and recording the electrical activities happening inside the brain. These wearable electroencephalography devices are used in the diagnosis of numerous neurological disorders like Parkinson’s disease, epilepsy, and Alzheimer's disease.
A wearable EEG device is a piece of technology that records the electrical signals in your brain. When you place an electrode against your scalp, it measures the different types of brain waves, including alpha, beta, delta and theta waves. EEG devices are used to diagnose epilepsy and other seizure disorders, because they are able to detect epileptic seizures before they happen. They are also used to monitor babies in neonatal intensive care units for signs of neurological problems. Despite their benefits, many people still don’t know what a wearable EEG device is or how it can be beneficial for them. Here are some things you need to know about these devices.
What are the major growths factors driving the EEG wearable device market?
Due to several factors such as the rising extent of the aged population, the growing research and development programs in the field of neurology, the growing incidences of neurovascular disorders, and the rising government projects to support the research studies are fuelling the worldwide wearable EEG device industry and will continue to dominate over the forecast period. Furthermore, augmented usage and high demand for good quality EEG devices are also responsible for positive industry growth. Other factors such as the growth in recent technological advancements in the electroencephalography devices in the diagnosis spectrum of neurological disorders are anticipated to boost the market growth in the future.
On the other hand, the high initial investment regarding the electroencephalography wearable devices is likely to hamper the market growth.
EEG devices are used for many different purposes, including helping diagnose seizure disorders, monitor new-borns for neurological problems, and to help determine the effectiveness of deep brain stimulation. They can also be used to find out what causes an individual’s seizures or other neurological problems.
An EEG device is often used as a first line of defence if an individual is shouldering a diagnosis of epilepsy. This is because it can detect epileptic seizures before they happen. It will also alert the patient if the seizure occurs, so that they can be protected from injury until the seizure ends.
WearableEEG devices are also useful in monitoring babies for signs of neurological problems. They are typically placed on babies who don’t respond properly to stimuli or cry enough, which could indicate that there may be something wrong with their brain development.
North America is dominating the global electroencephalography devices market and is likely to develop at the highest growth rate in the future due to numerous factors such as the existence of well-built healthcare infrastructure, successful healthcare activities, high expenditure capability of the consumer, the growing incidence of different sleep and neurodegenerative disorders in countries like the U.S.
The European region is also projected to witness the highest growth in the forthcoming years due to the establishment of multiple non-profit organizations, and the existence of a strong healthcare system.
The Asia-Pacific market is being propelled by the demand for EEG and an increase in the requirement for advanced technologies. Also, the development of private hospitals and neuro clinics in rural areas of Asia-Pacific is boosting the market.
Cadwell Laboratories Inc., Compumedics Limited, Nihon Kohden Corporation, Natus Medical Incorporated, Elekta AB, Neurosoft Ltd, Electrical Geodesics Inc., Brain Products GmbH, Emotiv Inc., NeuroWave Systems Inc., EB Neuro S.p.A, ANT Neuro, Advanced Brain Monitoring Inc., g.tec medical engineering GmbH, and Neuroelectrics are several players driving in the global EEG wearable device market.
Companies are actively engaged in strategic expansion and development of new products to capture significant revenue share. For instance, Nihon Kohden Corporation offers range medical electronic equipment, which includes EEGs, EMG measuring systems, ECGs, patient monitors, among others. The company's products are used in more than 100 countries, and it is the largest supplier of EEG products across the globe.
This report segments the global EEG wearable device market as follows:
Global EEG Wearable Device Market: By Component
Global EEG Wearable Device Market: By Delivery Model
Global EEG Wearable Device Market: By Functionality
Global EEG Wearable Device Market: Regional Segmentation Analysis